Recalls & Warnings January 17, 2018 Joint and Pain Relief Product Contains Undeclared Drug On January 17, 2018 Health Canada warned consumers that Linsen Double Caulis Plus, a supplement for joint pain, was found to contain the undeclared drug dexamethasone
Regular follow-up is essential to monitor weight loss progress, glycemic control, and any potential side effects
This is a process where your body becomes more efficient at the exercise youre doing and can impact your ability to break through a plateau
I keep an eye on this space because, despite considerable issues with nausea, vomiting, muscle loss, and even rare cases of sudden blindness, the GLP-1 RA drugs may offer the first real hope for patients with metabolic syndrome associated with chronic ulcers
While there is still not enough data on nutrient deficiencies specific to people on GLP-1 drugs, experts say these are the five most common nutrient deficiencies people can experience and what they can do to avoid them